Full-Time

Operations Associate

Granules

Granules

501-1,000 employees

Vertically integrated API and dosage manufacturer

No salary listed

Chantilly, VA, USA

In Person

Bachelor's

Category
Biology & Biotech (1)
Required Skills
GMP
FDA Regulations
SAP Products
Data Analysis

Get referred to Granules

See people who can refer or advise you

Requirements
  • A minimum Bachelor's degree in Healthcare Informatics or any scientific discipline is required.
  • A minimum of 2 years of experience in a current good manufacturing practice-regulated environment is required.
  • Experience with pharmaceutical manufacturing is highly preferred.
  • A background in current good manufacturing practice compliance and Drug Enforcement Administration compliance within the pharmaceutical manufacturing industry is required.
  • Experience writing and maintaining current good manufacturing practice documentation is required.
  • Experience with materials receipt and storage is required.
  • The ability to analyze data and information and assess and resolve complex issues is required.
  • The ability to work and communicate with cross-functional teams is required.
  • The ability to manage multiple priorities and reprioritize tasks is required.
  • The ability to adapt to company growth and evolving responsibilities is required.
  • Strong attention to detail and organization are required.
Responsibilities
  • Maintain awareness of emerging computational methods and technologies for inventory-control data analysis.
  • Prepare cycle-count reports and publish them periodically.
  • Document all changes, modifications, and issues in the database using the change-control program.
  • Create and maintain SAP master data, including the bill of materials master, resource master, production version, material master, and inspection plan.
  • Manage SAP as an inventory-control user.
  • Develop skills and provide user support for the production planning and materials management modules in SAP.
  • Use computer-based sequential processes to query databases.
  • Create data-management and error-checking procedures, including corrective actions.
  • Participate in implementing and enhancing automation in manufacturing activities.
  • Participate in computer-system validation activities for equipment involved in good manufacturing practice, including installation qualification, operational qualification, and performance qualification.
  • Analyze stock statements, production reports, consumption reports, shipment reports, and other data reports.
  • Manage master data by creating and editing records and generating reports in Blue Mountain Regulatory Asset Manager software.
  • Handle Drug Enforcement Administration materials and enter data for materials received in a pharmaceutical environment.
  • Write, revise, and review standard operating procedures related to the job functions.
  • Create purchase requisitions for manufacturing materials.
  • Participate in operational, safety, quality, and management initiatives.
Desired Qualifications
  • Experience in pharmaceutical manufacturing is highly preferred.

Granules India makes APIs, PFIs, and finished dosages, using large-scale, vertically integrated plants that control production from base chemicals to final medicines. Its products include common off-patent APIs like Paracetamol, Ibuprofen, Metformin, and Guaifenesin, and it is expanding into more complex areas such as MUPS, oncology, and peptide therapies with US FDA approvals. The company differentiates itself through full vertical integration, large scale, and a global manufacturing footprint that supports both contract manufacturing and its own branded products, offering supply security and cost competitiveness. Its goal is to deliver reliable, affordable medicines to customers worldwide while growing capabilities in complex therapies and pursuing sustainable practices like green chemistry.

Company Size

501-1,000

Company Stage

N/A

Total Funding

N/A

Headquarters

N/A

Founded

2014

Get referred to Granules

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Q4FY26 revenue rose 23% year over year to ₹14,706 million on April 29, 2026.
  • Granules Life Sciences received NAI and VAI outcomes in 2026, validating expansion.
  • Net debt fell to ₹4,021 million in FY26, strengthening funding for launches.

What critics are saying

  • FDA's February 26, 2025 Gagillapur warning letter delays approvals for future U.S. launches.
  • March 30, 2026 Chantilly FDA observations prove compliance problems persist across sites.
  • If Gagillapur remediation fails, Granules loses its U.S. growth engine and valuation rerates lower.

What makes Granules unique

  • Granules controls APIs, PFIs, and finished dosages, driving low-cost, high-volume manufacturing.
  • The 2026 Senn Chemicals acquisition added peptides and Swiss CDMO capabilities.
  • Granules Pharmaceuticals launched CNS generics, including lisdexamfetamine, with 180-day exclusivity in 2026.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Flexible Work Hours